LAMININ-DERIVED MULTI-DOMAIN PEPTIDES

Patent №

US 7,820,172

Granted

2010-10-26

Filed 2007

Owner

BIOSURACE ENGINEERING TECHNOLOGIES, INC.

+2 more

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

11757242

Multi-domain peptides including a heparin-binding peptide sequence covalently linked to a linker sequence, which linker sequence is covalently linked to a trifunctional amino acid residue forming a branch with two arms, with substantially similar (homodimeric) cellular attachment peptide sequences covalently linked, directly or through an intermediate, to each branch arm, where the sequences are cell binding analogs of or derived from laminin or a portion of laminin. Further provided are preparations for medical devices, pharmaceutical compositions and methods of using the same.

PlanningC07K 7/06C07K 14/78A61K 38/00

AI classification

Planning0.61
Vision0.01
Natural language0.00
AI hardware0.00
Machine learning0.00
Speech0.00
Knowledge representation0.00
Evolutionary computation0.00

Ownership

BIOSURACE ENGINEERING TECHNOLOGIES, INC.

assignment · 199350847

FERRING INTERNATONAL CENTER S.A.

assignment · 435390141

FERRING INTERNATIONAL CENTER S.A.

correct · 439700414

Assignors

ZAMORA, PAUL O., LIN, XINHUA, TAKAHASHI, KAZUYUKI

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC